Toll Free: 1-888-928-9744

Fate Therapeutics, Inc. - Product Pipeline Review - 2014

Published: May, 2014 | Pages: 32 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Fate Therapeutics, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Fate Therapeutics, Inc. - Product Pipeline Review - 2014', provides an overview of the Fate Therapeutics, Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Fate Therapeutics, Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Fate Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Fate Therapeutics, Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Fate Therapeutics, Inc.'s pipeline products

Reasons to buy

- Evaluate Fate Therapeutics, Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Fate Therapeutics, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Fate Therapeutics, Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Fate Therapeutics, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Fate Therapeutics, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Fate Therapeutics, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Fate Therapeutics, Inc. Snapshot 5
Fate Therapeutics, Inc. Overview 5
Key Information 5
Key Facts 5
Fate Therapeutics, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Fate Therapeutics, Inc. - Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products - Monotherapy 10
Fate Therapeutics, Inc. - Pipeline Products Glance 11
Fate Therapeutics, Inc. - Clinical Stage Pipeline Products 11
Phase II Products/Combination Treatment Modalities 11
Phase I Products/Combination Treatment Modalities 12
Fate Therapeutics, Inc. - Early Stage Pipeline Products 13
Preclinical Products/Combination Treatment Modalities 13
Discovery Products/Combination Treatment Modalities 14
Fate Therapeutics, Inc. - Drug Profiles 15
FT-1050 15
Product Description 15
Mechanism of Action 15
R&D Progress 15
FT-101 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
FT-201 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
FT-301 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
Hearing Restoration Program 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Second Generation HSC 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Wnt7a-�Based Protein Thearpeutics 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Fate Therapeutics, Inc. - Pipeline Analysis 26
Fate Therapeutics, Inc. - Pipeline Products by Molecule Type 26
Fate Therapeutics, Inc. - Recent Pipeline Updates 27
Fate Therapeutics, Inc. - Dormant Projects 29
Fate Therapeutics, Inc. - Locations And Subsidiaries 30
Head Office 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 32
Disclaimer 32
List of Tables
Fate Therapeutics, Inc., Key Information 5
Fate Therapeutics, Inc., Key Facts 5
Fate Therapeutics, Inc. - Pipeline by Indication, 2014 7
Fate Therapeutics, Inc. - Pipeline by Stage of Development, 2014 9
Fate Therapeutics, Inc. - Monotherapy Products in Pipeline, 2014 10
Fate Therapeutics, Inc. - Phase II, 2014 11
Fate Therapeutics, Inc. - Phase I, 2014 12
Fate Therapeutics, Inc. - Preclinical, 2014 13
Fate Therapeutics, Inc. - Discovery, 2014 14
Fate Therapeutics, Inc. - Pipeline by Molecule Type, 2014 26
Fate Therapeutics, Inc. - Recent Pipeline Updates, 2014 27
Fate Therapeutics, Inc. - Dormant Developmental Projects,2014 29 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify